{"doi":"10.3390/cancers14092152","title":"Tumor Microenvironment in Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: Interaction between Tumors and Immune Cells, and Potential Effects of Neuroendocrine Differentiation on the Tumor Microenvironment","abstract":"<jats:p>The tumor microenvironment is considered to play a pivotal role in various human malignancies. Neuroendocrine and non-neuroendocrine neoplasms are considered to have different tumor microenvironments. However, owing to differences in the systemic and/or local immune statuses, tumor microenvironments in different patients may be difficult to compare. Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs), although rare, could be useful for exploring the effects of neuroendocrine differentiation on the tumor microenvironment, because both neuroendocrine and non-neuroendocrine components are present in the same tumor. Here, we examined 33 cases of histologically confirmed MiNENs and evaluated the influence of neuroendocrine differentiation on the tumor microenvironment by comparing tumor-infiltrating lymphocytes, tumor-associated macrophages, and other relevant factors in the two components the same tumor. The immunoreactivity of those examined above was evaluated quantitatively. The values of vasohibin-1-positive density (p &lt; 0.0001) and immunoreactivity (p &lt; 0.0001) (representing the neoangiogenesis status) were significantly higher in neuroendocrine as compared to non-neuroendocrine areas of the same tumors. In addition, the Foxp3/CD8 (p = 0.0717) and the PD-1/CD8 ratios (p = 0.0176) (representing tumor immunity suppression) tend to increase in neuroendocrine carcinomas. Immunoreactivity of CD163, a marker of M2-like macrophages, was also higher in the neuroendocrine areas. Our findings indicate that neuroendocrine and non-neuroendocrine tumors differ from each other with respect to the characteristics of both tumor cells and the tumor microenvironment.</jats:p>","journal":"Cancers","year":2022,"id":606885,"datarank":0.3596842909197557,"base_score":2.3978952727983707,"endowment":2.3978952727983707,"self_citation_contribution":0.3596842909197557,"citation_network_contribution":0.0,"self_endowment_contribution":0.3596842909197557,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":10,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1558150,"name":"Fumiyoshi Fujishima","orcid":"0000-0001-8400-5551","position":1,"is_corresponding":false},{"id":412285,"name":"Hirofumi Watanabe","orcid":"0000-0003-0657-5385","position":2,"is_corresponding":false},{"id":1558153,"name":"Ikuro Sato","orcid":null,"position":3,"is_corresponding":false},{"id":1558155,"name":"Koh Miura","orcid":null,"position":4,"is_corresponding":false},{"id":1558156,"name":"Kazuhiro Sakamoto","orcid":null,"position":5,"is_corresponding":false},{"id":209927,"name":"Hiroyoshi Suzuki","orcid":null,"position":6,"is_corresponding":false},{"id":1558157,"name":"Takashi Sawai","orcid":null,"position":7,"is_corresponding":false},{"id":1558158,"name":"Yuko Itakura","orcid":null,"position":8,"is_corresponding":false},{"id":1558159,"name":"Tatsuya Hoshi","orcid":null,"position":9,"is_corresponding":false},{"id":1558160,"name":"Atsushi Kunimitsu","orcid":null,"position":10,"is_corresponding":false},{"id":1558161,"name":"Takuro Yamauchi","orcid":"0000-0002-2683-9109","position":11,"is_corresponding":false},{"id":1558162,"name":"Ryujiro Akaishi","orcid":null,"position":12,"is_corresponding":false},{"id":328420,"name":"Yohei Ozawa","orcid":"0000-0002-5136-8281","position":13,"is_corresponding":false},{"id":1558164,"name":"Toshiaki Fukutomi","orcid":null,"position":14,"is_corresponding":false},{"id":1558166,"name":"Hiroshi Okamoto","orcid":"0000-0002-9042-7096","position":15,"is_corresponding":false},{"id":1558168,"name":"Chiaki Sato","orcid":"0000-0003-1449-2053","position":16,"is_corresponding":false},{"id":1558169,"name":"Yusuke Taniyama","orcid":null,"position":17,"is_corresponding":false},{"id":1558170,"name":"Takashi Kamei","orcid":null,"position":18,"is_corresponding":false},{"id":307970,"name":"Hironobu Sasano","orcid":"0000-0002-6600-8641","position":19,"is_corresponding":false},{"id":1558147,"name":"Junichi Tsunokake","orcid":"0000-0003-0483-9068","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Tumor Microenvironment in Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: Interaction between Tumors and Immune Cells, and Potential Effects of Neuroendocrine Differentiation on the Tumor Microenvironment","abstract":"<jats:p>The tumor microenvironment is considered to play a pivotal role in various human malignancies. Neuroendocrine and non-neuroendocrine neoplasms are considered to have different tumor microenvironments. However, owing to differences in the systemic and/or local immune statuses, tumor microenvironments in different patients may be difficult to compare. Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs), although rare, could be useful for exploring the effects of neuroendocrine differentiation on the tumor microenvironment, because both neuroendocrine and non-neuroendocrine components are present in the same tumor. Here, we examined 33 cases of histologically confirmed MiNENs and evaluated the influence of neuroendocrine differentiation on the tumor microenvironment by comparing tumor-infiltrating lymphocytes, tumor-associated macrophages, and other relevant factors in the two components the same tumor. The immunoreactivity of those examined above was evaluated quantitatively. The values of vasohibin-1-positive density (p &lt; 0.0001) and immunoreactivity (p &lt; 0.0001) (representing the neoangiogenesis status) were significantly higher in neuroendocrine as compared to non-neuroendocrine areas of the same tumors. In addition, the Foxp3/CD8 (p = 0.0717) and the PD-1/CD8 ratios (p = 0.0176) (representing tumor immunity suppression) tend to increase in neuroendocrine carcinomas. Immunoreactivity of CD163, a marker of M2-like macrophages, was also higher in the neuroendocrine areas. Our findings indicate that neuroendocrine and non-neuroendocrine tumors differ from each other with respect to the characteristics of both tumor cells and the tumor microenvironment.</jats:p>","is_dataset_classified":null,"base_score":2.3978952727983707,"endowment":2.3978952727983707,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"35565281","pmcid":"PMC9100554","openalex_id":"https://openalex.org/W4224997209","authors":[],"funders":[{"funder_name":"Novartis (Japan)","grant_id":"funded by Novartis Pharma K.K.","title":null}],"total_grants":1,"fwci":1.3202,"citation_percentile":0.79339411,"influential_citations":0,"citation_trend":[{"year":2022,"count":2},{"year":2023,"count":3},{"year":2024,"count":2},{"year":2025,"count":2},{"year":2026,"count":1}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.mdpi.com/2072-6694/14/9/2152/pdf?version=1650963951","host_type":"journal"},{"url":"https://www.mdpi.com/2072-6694/14/9/2152/pdf?version=1650963951","host_type":"publisher"},{"url":"https://www.mdpi.com/2072-6694/14/9/2152/pdf","host_type":"publisher"},{"url":"https://doi.org/10.3390/cancers14092152","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/35565281","host_type":"repository"},{"url":"https://doaj.org/article/d8915401d8ad4de3af1b9482fe3ea74d","host_type":"repository"},{"url":"https://dx.doi.org/10.3390/cancers14092152","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9100554","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC9100554","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC9100554?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Neuroendocrine Tumor Research Advances","Lung Cancer Research Studies","Neuroblastoma Research and Treatments"],"mesh_terms":[],"keywords":["Tumor microenvironment","Neuroendocrine tumors","Neuroendocrine cell","Immune system","Neuroendocrine differentiation","Pathology","FOXP3","CD8","Biology","Tumor progression","Immunohistochemistry","Medicine","Cancer research","Internal medicine","Immunology","Cancer","Angiogenesis","Tumor infiltrating lymphocyte","immune suppression","Mixed Neuroendocrine Non-neuroendocrine Neoplasms"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-30T05:21:45.771159Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}